AbbVie (ABBV) Revenue & Quarterly History
Explore AbbVie Inc. (ABBV) revenue from 2023 through the latest reported quarter, with SEC-sourced comparisons and filing-constrained analysis.
Key takeaway
Quarter ended Mar 31, 2026 · FY2026 Q1
Revenue declined from the prior quarter but rose compared to the same quarter last year. The sequential decrease followed a period of steady growth in earlier quarters.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$15B
Revenue reported for this quarter.
Quarter-over-quarter
-9.7%
Change from the immediately preceding quarter.
Year-over-year
+12.4%
Change from the comparable year-ago quarter.
Trailing four quarters
$62.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2025 | $15.4B | +6.6% |
| Sep 30, 2025 | $15.8B | +9.1% |
| Dec 31, 2025 | $16.6B | +10.0% |
| Mar 31, 2026 | $15B | +12.4% |
Revenue performance
The reported revenue moved lower from the immediately preceding quarter, reversing the upward trend seen in the prior three quarters.
Quarterly comparison
Compared with the same quarter one year earlier, revenue was higher. The sequential decline contrasts with the year-ago increase.
What to watch
The sequential revenue drop may warrant attention given the prior pattern of consecutive quarterly gains.